Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Smruthi Organics Limited
WARNING LETTER
•Smruthi Organics Limited•October 18, 2013

Smruthi Organics Limited – FDA Warning Letter, Oct 18, 2013

Record Details

This FDA Warning Letter, dated March 6, 2014, was issued to Smruthi Organics Ltd following an inspection from October 15-18, 2013, at their Solapur, India facility. The inspection identified significant deviations from current Good Manufacturing Practice (CGMP) for Active Pharmaceutical Ingredients (APIs), rendering their APIs adulterated.

Key violations include: 1. **Failure to maintain complete and accurate laboratory test data:** This involved missing written explanations for HPLC audit trail deletions, lack of electronic raw data retention instructions, absence of integration parameters for HPLC analyses, incomplete raw data for test method validation/verification (specifically for residual solvents), performing unjustified "trial injections" before official tests, and unauthentic calibration/media preparation records where signees were not present. 2. **Failure to maintain and make available production and control records:** The firm was found to have blended out-of-specification (OOS) API batches, and relevant records were initially stated as destroyed, then later claimed to be misplaced. 3. **Inadequate investigations of critical deviations:** Investigations into particulate matter complaints in API batches were incomplete and inconclusive.

Additional deficiencies noted include a duplicate logbook with altered pages, inability to recover HPLC integration parameters for retained samples, and a general lack of controls to prevent data manipulation.

The FDA requires a comprehensive corrective action plan addressing these issues, including a retrospective review of all affected data, re-

Company
Smruthi Organics Limited
Inspection date
October 18, 2013
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Steven J. Lynn
View Company Profile

ID · 307d369f-4f0c-4504-bcf0-f8d36d44a87a

Violation Codes5
21 U.S.C. 351(a)(2)(B)FD&C Act 501(a)(2)(B)21 U.S.C. 356C(a)(1)21 U.S.C. 381(a)(3)FD&C Act 801(a)(3)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Smruthi Organics Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.